Joel Marcus

Track

Insider profile

Currently holds positions in Alexandria Real Estate Equities Inc, Intra-Cellular Therapies Inc and MeiraGTx Holdings PLC

Performance

Overall performance
3.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
88 10% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 345%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Executive Chairman of the Board Alexandria Real Estate Equities Inc April 23, 2018 -
Independent Director Intra-Cellular Therapies Inc Jan. 1, 2014 -
Independent Director MeiraGTx Holdings PLC June 1, 2015 -
Independent Director Atara Biotherapeutics Inc Nov. 1, 2013 - March 29, 2019
Chairman of the Board, President, Chief Executive Officer Alexandria Real Estate Equities Inc Feb. 17, 2009 - April 23, 2018
Independent Director Rexford Industrial Realty Inc July 24, 2013 - Jan. 12, 2015
Independent Trustee PennyMac Mortgage Investment Trust Aug. 1, 2009 - Aug. 7, 2012
Joel Marcus's trades of Alexandria Real Estate Equities Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-07 2026-05-06
B Purchase
80,280 -22.5%
351.70
US$4,533,643 		80,280 -22.5% 351.70 US$4,533,643
2026-05-07 2026-05-06
B Purchase
89,604 +17.7%
111.97
US$2,467,858 		89,604 +17.7% 111.97 US$2,467,858
2026-05-06 2026-05-05
B Purchase
29,833 -23.7%
447.82
US$435,627 		29,833 -23.7% 447.82 US$435,627
2026-05-06 2026-05-05
B Purchase
3,832 +0.7%
42.76
US$163,856 		3,832 +0.7% 42.76 US$163,856
2026-05-06 2026-05-05
B Purchase
2,062 +0.4%
41.89
US$86,377 		2,062 +0.4% 41.89 US$86,377
2026-05-05 2026-05-04
B Purchase
10,000 +1.8%
41.02
US$410,200 		10,000 +1.8% 41.02 US$410,200
2026-02-13 2026-02-12
B Purchase
7,700 +1.4%
54.31
US$418,187 		7,700 +1.4% 54.31 US$418,187
2026-02-13 2026-02-12
B Purchase
17,300 +3.2%
53.74
US$929,702 		17,300 +3.2% 53.74 US$929,702
2024-02-28 2024-02-26
S Sale
7,500 -1.7%
118.92
US$891,900 		7,500 -1.7% 118.92 US$891,900
2024-02-27 2024-02-26
S Sale
299 -0.7%
69.60
US$20,810 		299 -0.7% 69.60 US$20,810
2024-02-27 2024-02-26
S Sale
17,658 -30.6%
69.07
US$1,219,638 		17,658 -30.6% 69.07 US$1,219,638
2024-02-27 2024-02-26
S Sale
8,371 -12.7%
67.83
US$567,805 		8,371 -12.7% 67.83 US$567,805
2024-02-26 2024-02-26
PrS Proposed sale
26,328
68.68
US$1,808,212 		26,328 68.68 US$1,808,212
2024-02-26 2024-02-26
PrS Proposed sale
7,500
119.82
US$898,650 		7,500 119.82 US$898,650
2023-05-10 2023-05-08
S Sale
7,500 -2.1%
122.20
US$916,500 		7,500 -2.1% 122.20 US$916,500
2023-05-08 2023-05-08
PrS Proposed sale
9,500
121.70
US$1,156,150 		9,500 121.70 US$1,156,150
2023-02-09 2023-02-07
S Sale
9,000 -2.3%
168.00
US$1,512,000 		9,000 -2.3% 168.00 US$1,512,000
2022-12-21 2022-12-19
S Sale
5,000 -14.6%
50.82
US$254,100 		5,000 -14.6% 50.82 US$254,100
2022-12-14 2022-12-12
S Sale
6,500 -1.9%
150.00
US$975,000 		6,500 -1.9% 150.00 US$975,000
2022-12-07 2022-12-05
S Sale
2,500 -0.7%
152.00
US$380,000 		2,500 -0.7% 152.00 US$380,000
2022-11-08 2022-11-07
S Sale
5,000 -12.7%
52.11
US$260,558 		5,000 -12.7% 52.11 US$260,558
2022-11-08 2022-11-07
S Sale
5,000 -11.3%
52.49
US$262,464 		5,000 -11.3% 52.49 US$262,464
2022-08-12 2022-08-11
S Sale
10,000 -18.4%
59.22
US$592,200 		10,000 -18.4% 59.22 US$592,200
2022-05-13 2022-05-12
S Sale
10,000 -15.6%
55.00
US$550,000 		10,000 -15.6% 55.00 US$550,000
2022-03-09 2022-03-08
S Sale
10,000 -25.7%
52.89
US$528,900 		10,000 -25.7% 52.89 US$528,900
2022-03-09 2022-03-08
S Sale
5,000 -11.4%
52.25
US$261,250 		5,000 -11.4% 52.25 US$261,250
2022-03-09 2022-03-07
S Sale
5,000 -10.2%
54.52
US$272,600 		5,000 -10.2% 54.52 US$272,600
2021-05-05 2021-05-04
S Sale
5,000 -1.5%
180.41
US$902,050 		5,000 -1.5% 180.41 US$902,050
2021-05-05 2021-05-03
S Sale
15,000 -4.2%
180.33
US$2,704,950 		15,000 -4.2% 180.33 US$2,704,950
2021-03-04 2021-03-02
S Sale
15,250 -17.4%
34.93
US$532,682 		15,250 -17.4% 34.93 US$532,682
2020-12-22 2020-12-22
US Korro Bio Inc (KRRO)
S Sale
10,000 -3.6%
34.27
US$342,738 		10,000 -3.6% 34.27 US$342,738
2020-12-22 2020-12-22
US Korro Bio Inc (KRRO)
S Sale
1,120 -0.4%
33.82
US$37,879 		1,120 -0.4% 33.82 US$37,879
2020-12-22 2020-12-22
US Korro Bio Inc (KRRO)
S Sale
7,441 -2.6%
32.97
US$245,339 		7,441 -2.6% 32.97 US$245,339
2020-12-22 2020-12-22
US Korro Bio Inc (KRRO)
S Sale
1,439 -0.5%
32.09
US$46,178 		1,439 -0.5% 32.09 US$46,178
2020-12-22 2020-12-21
US Korro Bio Inc (KRRO)
S Sale
10,000 -3.3%
30.35
US$303,521 		10,000 -3.3% 30.35 US$303,521
2020-12-22 2020-12-18
US Korro Bio Inc (KRRO)
S Sale
8,412 -2.7%
38.27
US$321,910 		8,412 -2.7% 38.27 US$321,910
2020-12-22 2020-12-18
US Korro Bio Inc (KRRO)
S Sale
4,300 -1.4%
37.21
US$159,991 		4,300 -1.4% 37.21 US$159,991
2020-12-22 2020-12-18
US Korro Bio Inc (KRRO)
S Sale
2,864 -0.9%
36.03
US$103,191 		2,864 -0.9% 36.03 US$103,191
2020-12-22 2020-12-18
US Korro Bio Inc (KRRO)
S Sale
1,814 -0.6%
34.90
US$63,306 		1,814 -0.6% 34.90 US$63,306
2020-12-22 2020-12-18
US Korro Bio Inc (KRRO)
S Sale
2,310 -0.7%
33.92
US$78,359 		2,310 -0.7% 33.92 US$78,359
2020-08-19 2020-08-17
S Sale
3,500 -1.1%
173.51
US$607,285 		3,500 -1.1% 173.51 US$607,285
2020-08-19 2020-08-17
S Sale
4,000 -1.2%
171.52
US$686,080 		4,000 -1.2% 171.52 US$686,080
2020-08-12 2020-08-12
S Sale
7,959 -100.0%
14.15
US$112,620 		7,959 -100.0% 14.15 US$112,620
2020-08-12 2020-08-11
S Sale
7,500 -48.5%
13.86
US$103,950 		7,500 -48.5% 13.86 US$103,950
2020-08-04 2020-08-03
S Sale
10,000 -2.9%
177.00
US$1,770,000 		10,000 -2.9% 177.00 US$1,770,000